{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:31:00Z","timestamp":1781623860217,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12282-026-01836-5","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:14:07Z","timestamp":1771236847000},"page":"544-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8446-9071","authenticated-orcid":false,"given":"Jun","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6172-3701","authenticated-orcid":false,"given":"Bingbing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9283-0738","authenticated-orcid":false,"given":"Wanying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4787-6734","authenticated-orcid":false,"given":"Huijun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0192-5130","authenticated-orcid":false,"given":"Nvzhu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8935-3687","authenticated-orcid":false,"given":"Wenna","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1661-6677","authenticated-orcid":false,"given":"Yaoquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1469-9666","authenticated-orcid":false,"given":"Lishan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7199-8605","authenticated-orcid":false,"given":"Wei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"3","key":"1836_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"1","key":"1836_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1836_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670\u201391.","journal-title":"Cell"},{"issue":"6","key":"1836_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/jnci\/djr046","volume":"103","author":"L Bernstein","year":"2011","unstructured":"Bernstein L, Lacey JV JR. Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative? J Natl Cancer Inst. 2011;103(6):451\u20133.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1836_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41392-023-01689-w","volume":"8","author":"X Liu","year":"2023","unstructured":"Liu X, Zhang X, Shao Z, et al. Pyrotinib and Chrysin synergistically potentiate autophagy in HER2-positive breast cancer . Signal Transduct Target Therapy. 2023;8(1):463.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"1836_CR6","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1836_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00428-017-2065-7","volume":"470","author":"IA Moln\u00e1r","year":"2017","unstructured":"Moln\u00e1r IA, Moln\u00e1r B, V\u00edzkeleti L, et al. Breast carcinoma subtypes show different patterns of metastatic behavior. Virchows Arch. 2017;470(3):275\u201383.","journal-title":"Virchows Arch"},{"issue":"1","key":"1836_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2008.19.9844","volume":"28","author":"S Dawood","year":"2010","unstructured":"Dawood S, Broglio K, Buzdar A U, et al. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review . J Clin Oncology: Official J Am Soc Clin Oncol. 2010;28(1):92\u20138.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"4","key":"1836_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.breast.2012.12.006","volume":"22","author":"EM Olson","year":"2013","unstructured":"Olson EM, Najita JS, Sohl J, et al. Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era. Breast. 2013;22(4):525\u201331.","journal-title":"Breast"},{"key":"1836_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092272","author":"B Medeiros","year":"2019","unstructured":"Medeiros B, Allan AL. Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20092272.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1836_CR11","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/cam4.1370","volume":"7","author":"W Xiao","year":"2018","unstructured":"Xiao W, Zheng S, Liu P, et al. Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study. Cancer Med. 2018;7(3):922\u201330.","journal-title":"Cancer Med"},{"issue":"8","key":"1836_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-017-9871-9","volume":"34","author":"DJ Press","year":"2017","unstructured":"Press DJ, Miller ME, Liederbach E, et al. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype. Clin Exp Metastasis. 2017;34(8):457\u201365.","journal-title":"Clin Exp Metastasis"},{"issue":"3","key":"1836_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4274\/ejbh.galenos.2021.2021-4-3","volume":"17","author":"H Zhu","year":"2021","unstructured":"Zhu H, Do\u011fan BE. American Joint Committee on Cancer\u2019s staging system for breast cancer, eighth edition: summary for clinicians. Eur J Breast Health. 2021;17(3):234\u20138.","journal-title":"Eur J Breast Health"},{"issue":"18","key":"1836_CR14","doi-asserted-by":"publisher","first-page":"18597","DOI":"10.1002\/cam4.6469","volume":"12","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liang Y, Ye F, et al. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database. Cancer Med. 2023;12(18):18597\u2013610.","journal-title":"Cancer Med"},{"issue":"11","key":"1836_CR15","doi-asserted-by":"publisher","first-page":"6710","DOI":"10.21037\/tcr-20-2379","volume":"9","author":"LJ Ye","year":"2020","unstructured":"Ye LJ, Suo HD, Liang CY, et al. Nomogram for predicting the risk of bone metastasis in breast cancer: a SEER population-based study. Transl Cancer Res. 2020;9(11):6710\u20139.","journal-title":"Transl Cancer Res"},{"issue":"7","key":"1836_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27837","volume":"10","author":"L Zhang","year":"2024","unstructured":"Zhang L, Qiao Z, Yao Y, et al. A prognostic model for triple-negative breast cancer patients with liver metastasis: a population-based study. Heliyon. 2024;10(7):e27837.","journal-title":"Heliyon"},{"issue":"7","key":"1836_CR17","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1002\/cam4.5575","volume":"12","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhang L, Tian W, et al. Prognosis prediction and risk factors for triple-negative breast cancer patients with brain metastasis: A population-based study. Cancer Med. 2023;12(7):7951\u201361.","journal-title":"Cancer Med"},{"issue":"Suppl 2","key":"1836_CR18","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.breast.2015.07.011","volume":"24","author":"N Harbeck","year":"2015","unstructured":"Harbeck N. Insights into biology of luminal HER2 vs. enriched HER2 subtypes: therapeutic implications. Breast (Edinburgh, Scotland). 2015;24(Suppl 2):S44-8.","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"11","key":"1836_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242155","volume":"15","author":"H Lin","year":"2020","unstructured":"Lin H, Wu Y, Liang G, et al. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery. PLoS One. 2020;15(11):e0242155.","journal-title":"PLoS One"},{"issue":"1","key":"1836_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07565-x","volume":"12","author":"W Liu","year":"2022","unstructured":"Liu W, Han Y. Clinical outcomes and a nomogram for de novo metastatic breast cancer with lung metastasis: a population-based study. Sci Rep. 2022;12(1):3597.","journal-title":"Sci Rep"},{"issue":"2","key":"1836_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10549-019-05385-8","volume":"178","author":"YL Liu","year":"2019","unstructured":"Liu YL, Wang DW, Yang ZC, et al. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database. Breast Cancer Res Treat. 2019;178(2):379\u201388.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"1836_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/pon.1499","volume":"18","author":"G Goldzweig","year":"2009","unstructured":"Goldzweig G, Andritsch E, Hubert A, et al. How relevant is marital status and gender variables in coping with colorectal cancer? A sample of middle-aged and older cancer survivors. Psycho-Oncol. 2009;18(8):866\u201374.","journal-title":"Psycho-Oncol"},{"issue":"6","key":"1836_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000455956","volume":"92","author":"P De Luca R, Dorangricchia","year":"2017","unstructured":"De Luca R, Dorangricchia P. The role of couples\u2019 attachment styles in patients\u2019 adjustment to cancer. Oncology. 2017;92(6):325\u201334.","journal-title":"Oncology"},{"key":"1836_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1415","volume":"361","author":"A Pitman","year":"2018","unstructured":"Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer. BMJ. 2018;361:k1415.","journal-title":"BMJ"},{"issue":"9","key":"1836_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-019-0228-0","volume":"15","author":"G Russell","year":"2019","unstructured":"Russell G, Lightman S. The human stress response. Nat Rev Endocrinol. 2019;15(9):525\u201334.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"1836_CR26","first-page":"5388","volume":"11","author":"M Mcdonald K A, Oshi","year":"2021","unstructured":"Mcdonald K A, Oshi M, Kawaguchi T, et al. Development of KAM score to predict metastasis and worse survival in breast cancer. Am J Cancer Res. 2021;11(11):5388\u2013401.","journal-title":"Am J Cancer Res"},{"issue":"Suppl 3","key":"1836_CR27","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S0959-8049(11)70142-3","volume":"47","author":"J Ruiterkamp","year":"2011","unstructured":"Ruiterkamp J, Ernst MF. The role of surgery in metastatic breast cancer. European journal of cancer (Oxford, England\u202f: 1990). 2011;47(Suppl 3):S6-22.","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"11","key":"1836_CR28","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1245\/s10434-018-6494-6","volume":"25","author":"A Soran","year":"2018","unstructured":"Soran A, Ozmen V. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 2018;25(11):3141\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"1836_CR29","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.21037\/tcr.2020.01.60","volume":"9","author":"T Tsukioki","year":"2020","unstructured":"Tsukioki T, Shien T, Doihara H. Effect of local surgery on outcomes of stage IV breast cancer. Transl Cancer Res. 2020;9(8):5102\u20137.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"1836_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59908-1","volume":"10","author":"R Gera","year":"2020","unstructured":"Gera R, Chehade H, Wazir U, et al. Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: a meta-analysis. Sci Rep. 2020;10(1):2952.","journal-title":"Sci Rep"},{"issue":"5","key":"1836_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"J Gradishar W J, Moran M S, Abraham","year":"2024","unstructured":"Gradishar W J, Moran M S, Abraham J, et al. Breast Cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2024;22(5):331\u201357.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"3","key":"1836_CR32","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2018.05.04","volume":"7","author":"M Yao","year":"2018","unstructured":"Yao M, Fu P. Advances in anti-HER2 therapy in metastatic breast cancer. Chin Clin Oncol. 2018;7(3):27.","journal-title":"Chin Clin Oncol"},{"issue":"10074","key":"1836_CR33","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134\u201350.","journal-title":"Lancet"},{"issue":"10","key":"1836_CR34","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/bjc.2014.388","volume":"111","author":"JC Singh","year":"2014","unstructured":"Singh JC, Jhaveri K, Esteva FJ. HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development. Br J Cancer. 2014;111(10):1888\u201398.","journal-title":"Br J Cancer"},{"key":"1836_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221122703","volume":"29","author":"L Hai","year":"2022","unstructured":"Hai L, Feng Y, Zhao J, et al. An improved nomogram to reduce false-positive biopsy rates of breast imaging reporting and data system ultrasonography category 4A lesions. Cancer Control. 2022;29:10732748221122703.","journal-title":"Cancer Control"},{"issue":"22","key":"1836_CR36","doi-asserted-by":"publisher","first-page":"8114","DOI":"10.1002\/cam4.4326","volume":"10","author":"X Lyu","year":"2021","unstructured":"Lyu X, Luo B. Prognostic factors and survival prediction in HER2-positive breast cancer with bone metastases: a retrospective cohort study. Cancer Med. 2021;10(22):8114\u201326.","journal-title":"Cancer Med"},{"issue":"1","key":"1836_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1186\/s12905-024-03526-w","volume":"24","author":"Y Chen","year":"2024","unstructured":"Chen Y, Qiu Y, Shen H, et al. Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study. BMC Womens Health. 2024;24(1):675.","journal-title":"BMC Womens Health"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01836-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01836-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01836-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:57:10Z","timestamp":1772621830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01836-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1836"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01836-5","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interest.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate\u00a0"}},{"value":"All authors have agreed to the publication, and it has not been published in other journals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}